Business Daily from THE HINDU group of publications
Saturday, Feb 09, 2008
ePaper | Mobile/PDA Version


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Alliances & Joint Ventures
Get Latest BSE Quote
Dr Reddy’s pact with SkyePharma

Hyderabad, Feb. 8

Dr Reddy’s Laboratories Ltd has entered into an agreement with London-based SkyePharma PLC to undertake a feasibility study of a product (which has not been disclosed) utilising two of SkyePharma’s proprietary drug delivery systems. The costs of the study would be borne by the Hyderabad-based pharma major while SkyePharma would also receive an upfront payment. If the feasibility study is successful, full development activities would begin later this year, according to a release.

Our Bureau

More Stories on : Alliances & Joint Ventures | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Heritage Foods approves share issue


PSUs contribute bulk of dividend payout
BHEL wins Rs 3,390 cr contract
L&T bags Rs 1,107-cr orders from SAIL
Adecco buys industrial staffing firm
Ceat in talks with partners for 2 greenfield projects
Beko Tech sets up first India plant at Hyderabad
Dalmia Cements planning to double capacity
IFC, Cairn open centre for small biz development in Rajasthan
SAIL, Steel Complex in pact for joint venture
Strides Arcolab set to take majority stake in Australia’s Genepharm
Dr Reddy’s pact with SkyePharma
Merck seeking alliances to accelerate drug discovery
Mitsubishi Corp ties up with Coimbatore co
Nod for transfer of BWEL to Rlys after financial recast package
Rs 200-cr interim grant to FACT approved
Oil India confident of IPO in March-end
Messe Düsseldorf hopes to double revenue

BusinessLine E-paper


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line